Geoffrey S Ginsburg

Image of Geoffrey S Ginsburg

Professor of Medicine

Contact Information:
Education:
M.D.Boston University1984
Ph.D.Boston University1984
Recent Publications: (More Publications)
    • NL Lugogo, GS Ginsburg, LG Que, Genetic profiling and tailored therapy in asthma: Are we there yet?, Current opinion in molecular therapeutics, England, vol 9 no. 6 (2007), pp. 528-37 [abs]
    • GS Ginsburg, Regression of atherosclerosis with therapeutic antibodies pipe cleaner or pipe dream?, Journal of the American College of Cardiology, United States, vol 50 no. 24 (2007), pp. 2319-21
    • A Parker, ES Izmailova, J Narang, S Badola, T Le, R Roubenoff, GS Ginsburg, A Maier, JS Coblyn, NA Shadick, ME Weinblatt, Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate., The Journal of rheumatology, Canada, vol 34 no. 9 (2007), pp. 1817-22 [abs]
    • GS Ginsburg, SH Shah, JJ McCarthy, Taking cardiovascular genetic association studies to the next level., Journal of the American College of Cardiology, United States, vol 50 no. 10 (2007), pp. 930-2 [abs]
    • HK Dressman, GG Muramoto, NJ Chao, S Meadows, D Marshall, GS Ginsburg, JR Nevins, JP Chute, Gene expression signatures that predict radiation exposure in mice and humans., PLoS medicine, United States, vol 4 no. 4 (2007), pp. e106 [abs]
    • HK Dressman, A Berchuck, G Chan, J Zhai, A Bild, R Sayer, J Cragun, J Clarke, RS Whitaker, L Li, J Gray, J Marks, GS Ginsburg, A Potti, M West, JR Nevins, JM Lancaster, An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, United States, vol 25 no. 5 (2007), pp. 517-25 [abs]
    • A Potti, HK Dressman, A Bild, RF Riedel, G Chan, R Sayer, J Cragun, H Cottrill, MJ Kelley, R Petersen, D Harpole, J Marks, A Berchuck, GS Ginsburg, P Febbo, J Lancaster, JR Nevins, Genomic signatures to guide the use of chemotherapeutics., Nature medicine, United States, vol 12 no. 11 (2006), pp. 1294-300 [abs]
    • GS Ginsburg, D Seo, C Frazier, Microarrays coming of age in cardiovascular medicine: standards, predictions, and biology., Journal of the American College of Cardiology, United States, vol 48 no. 8 (2006), pp. 1618-20
    • GS Ginsburg, M Angrist, R Cook-Deegan, Public health. Genomics and medicine at a crossroads in Chernobyl., Science (New York, N.Y.), United States, vol 314 no. 5796 (2006), pp. 62-3
    • SC Stallings, D Huse, SN Finkelstein, WH Crown, WP Witt, J Maguire, AJ Hiller, AJ Sinskey, GS Ginsburg, A framework to evaluate the economic impact of pharmacogenomics., Pharmacogenomics, England, vol 7 no. 6 (2006), pp. 853-62 [abs]
    • A Potti, S Mukherjee, R Petersen, HK Dressman, A Bild, J Koontz, R Kratzke, MA Watson, M Kelley, GS Ginsburg, M West, DH Harpole, JR Nevins, A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer., The New England journal of medicine, United States, vol 355 no. 6 (2006), pp. 570-80 [abs]
    • D Seo, GS Ginsburg, PJ Goldschmidt-Clermont, Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications., Journal of the American College of Cardiology, United States, vol 48 no. 2 (2006), pp. 227-35 [abs]
    • SB Haga, GS Ginsburg, Prescribing BiDil: is it black and white?, Journal of the American College of Cardiology, United States, vol 48 no. 1 (2006), pp. 12-4 [abs]
    • CM Cotten, GS Ginsburg, RN Goldberg, MC Speer, Genomic analyses: a neonatology perspective., The Journal of pediatrics, United States, vol 148 no. 6 (2006), pp. 720-6
    • M West, GS Ginsburg, AT Huang, JR Nevins, Embracing the complexity of genomic data for personalized medicine., Genome research, United States, vol 16 no. 5 (2006), pp. 559-66 [abs]
    • GS Ginsburg, SB Haga, Translating genomic biomarkers into clinically useful diagnostics., Expert review of molecular diagnostics, England, vol 6 no. 2 (2006), pp. 179-91 [abs]
    • GS Ginsburg, RP Konstance, JS Allsbrook, KA Schulman, Implications of pharmacogenomics for drug development and clinical practice., Archives of internal medicine, United States, vol 165 no. 20 (2005), pp. 2331-6 [abs]
    • GS Ginsburg, MP Donahue, LK Newby, Prospects for personalized cardiovascular medicine: the impact of genomics., Journal of the American College of Cardiology, United States, vol 46 no. 9 (2005), pp. 1615-27 [abs]
    • D Seo, GS Ginsburg, Genomic medicine: bringing biomarkers to clinical medicine., Current opinion in chemical biology, England, vol 9 no. 4 (2005), pp. 381-6 [abs]
    • HF Willard, M Angrist, GS Ginsburg, Genomic medicine: genetic variation and its impact on the future of health care., Philosophical transactions of the Royal Society of London. Series B, Biological sciences, England, vol 360 no. 1460 (2005), pp. 1543-50 [abs]
    • E Abrahams, GS Ginsburg, M Silver, The Personalized Medicine Coalition: goals and strategies., American journal of pharmacogenomics : genomics-related research in drug development and clinical practice, New Zealand, vol 5 no. 6 (2005), pp. 345-55 [abs]
    • JS Ross, DP Schenkein, R Pietrusko, M Rolfe, GP Linette, J Stec, NE Stagliano, GS Ginsburg, WF Symmans, L Pusztai, GN Hortobagyi, Targeted therapies for cancer 2004., American journal of clinical pathology, United States, vol 122 no. 4 (2004), pp. 598-609 [abs]
    • JS Ross, GS Ginsburg, Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care., Expert review of molecular diagnostics, England, vol 2 no. 6 (2002), pp. 531-41 [abs]
    • JM Meyer, GS Ginsburg, The path to personalized medicine., Current opinion in chemical biology, England, vol 6 no. 4 (2002), pp. 434-8 [abs]
    • GS Ginsburg, JJ McCarthy, Personalized medicine: revolutionizing drug discovery and patient care., Trends in biotechnology, England, vol 19 no. 12 (2001), pp. 491-6 [abs]